---
format: 
  revealjs:
    logo: images/circle-cropped.png
    link-external-newwindow: true
    theme: [dark, mycustom.scss]
    width: 1600
    height: 900
    slide-number: c/t
    code-line-numbers: false
    chalkboard: false
editor: visual
---

<br> <br>

<h1>Smoking-Related Lung Disease</h1>

<br>

<h2>Howard Mann, M.D.</h2>

<h2>University of Utah School of Medicine</h2>

<br><br><br><br>

<h2>`r fontawesome::fa("envelope", "white")`   howard.mann\@utah.edu</h2>

<h2>`r fontawesome::fa("link", "white")`   [howardmann.us](http://howardmann.us)</h2>

<br>

<h2>URL: https://howardm.github.io/Smoking-Related Lung Disease</h2>

![](images/UhealthLogo.png){.absolute top="325" right="300" width="300"}

## Contents

<br>

Common diseases

-   COPD
-   Langerhan's Cell Histiocytosis
-   Pulmonary accumulation of smoker's macrophages
-   Smoking-Related Interstitial Fibrosis
-   Combined Pulmonary Fibrosis and Emphysema Syndrome

<br>

Rare association

-   Acute Eosinophilic Pneumonia

Smoking-related lung cancer will be covered separately.

## COPD

<br>

[Clinical definition^1^]{style="color: white; font-size: 36px;"}

<br>

[Lung disease characterized by chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.]{style="color: white; font-size: 36px;"}

<br>

[1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) https://goldcopd.org/]{style="color: white; font-size: 24px;"}

## 

<br> <br><br>

::: columns
::: {.column width="50%"}
![](images/PFTs.jpg){fig-align="center" width="100%"}
:::

::: {.column width="50%"}
![](images/lungvolumes.jpg){fig-align="center" width="88%"}
:::
:::

## 

<br> <br>

::: columns
::: {.column width="50%"}
![](images/tlcdisease.jpg){fig-align="center" width="100%"}
:::

::: {.column width="50%"}
![](images/eyeballingTLC.jpg){fig-align="center" width="100%"}

Increased RV (a static lung volume) in COPD
:::
:::

## Spirometry in the diagnosis of COPD

<br>

![](images/spirometrydefinitions.jpg){fig-align="center" width="95%"}

## COPD and associated conditions

<br>

**Chronic Bronchitis**

The presence of a chronic productive cough for 3 months in each of 2 successive years, provided that other causes of chronic cough have been ruled out

<br>

**Emphysema**

Destruction of alveolar walls and the permanent enlargement of the airspaces distal to the terminal bronchioles, without obvious fibrosis

<br>

**Asthma**

Reversible smooth muscle contraction that narrows the airway lumen, limiting expiratory airflow and resulting in symptoms including wheeze, cough, and exertion dyspnea

## COPD phenotypes

<br>

::: columns
::: {.column width="30%"}
<br>

-   Airway-dominant phenotype

-   Emphysema-dominant phenotype

-   Mixed phenotype

We can make these distinctions on CT.
:::

::: {.column width="70%"}
![](images/pathologycopd.jpg){fig-align="center" width="100%"}
:::
:::

## Hyperinflation in COPD

<br>

::: columns
::: {.column width="30%"}
<br> The effects on lung volumes correlate well with functional capacity and symptoms

<br>

Static hyperinflation

-   diminished elastic recoil of emphysematous lung
-   significant in severe bullous emphysema

Dynamic hyperinflation

-   inability to exhale all inspired air through narrowed airways
:::

::: {.column width="70%"}
![](images/hyperinflationCXR.jpg){fig-align="center" width="60%"}
:::
:::

## Emphysema-dominant COPD phenotype

<br>

![](images/emphysemacxranalyzevessels.jpg){fig-align="center" width="100%"}

## 

<br>

![](images/emphysemacxrCT.jpg){fig-align="center" width="100%"}

## 

<br>

![](images/emphysemacxrCTtwo.jpg){fig-align="center" width="100%"}

## Airway-dominant COPD phenotype -- CXR

<br>

![](images/airwaydominantcxr.jpg){fig-align="center" width="100%"}

## Airway-dominant COPD phenotype -- CT

<br>

![](images/airwaydominantCT.jpg){fig-align="center" width="100%"}

<br>

Note: bronchial wall thickening

## Comparison between emphysema- and airway-dominant COPD

<br>

![](images/comparisonCTs.jpg){fig-align="center" width="100%"}

## Langerhan's Cell Histiocytosis

<br>

What are Langerhan's Cells ?

-   dendritic antigen-presenting cells
-   migrate from bone marrow to skin and lungs
-   histiocytes are tissue-resident macrophages
-   chracteristic morphology and cell surface receptors: CD1a; S-100; langerin (CD207)

The evolution of pulmonary histiocytosis (PLCH) accounts for the imaging findings:

-   nodules reflective of cellular proliferation -- often stellate-shaped
-   cavitation in nodules
-   formation of irregularly-shaped cystic spaces \>\> chronic "burned-out" disease that looks like panlobular emphysema

## Nodular PLCH

<br>

![](images/nodulesplch.jpg){fig-align="center" width="100%"}

## Nodular PLCH

<br> <br>

![](images/plchnodulesunecessarybiopsy.jpg){fig-align="center" width="100%"}

<br>

::: {.callout-note appearance="minimal"}
Key Points

-   Nodules of PLCH are typically upper-lobe predominant.
-   MIPS images may reveal additional subcentimeter nodules
:::

## Nodular and cystic PLCH

<br> <br>

![](images/plchnodulescysts.jpg){fig-align="center" width="100%"}

<br>

::: {.callout-note appearance="minimal"}
Note the predominant involvement of the upper lungs.
:::

## How would you report this radiograph ?

<br>

![](images/plchscxr.jpg){fig-align="center" width="100%"}

## The corresponding CT

<br>

![](images/plchcxrwithCT.jpg){fig-align="center" width="100%"}

::: {.callout-note icon="false"}
## The very definition of an *Aunt Minnie*

-   Nothing (!) else looks like this.
:::

## Nothing else -- really!

Another *Aunt Minnie*

<br>

![](images/anothercasecysticplch.jpg){fig-align="center" width="100%"}



## When the cystic disease of PLCH is very bad.

<br> <br>

![](images/plchbadcysticdisease.jpg){fig-align="center" width="100%"}

## Challenge case

<br>

::: columns
::: {.column width="50%"}
![](images/challengecase.jpg){fig-align="center" width="100%"}
:::

::: {.column width="50%"}
```{=html}
<div style="text-align:center;">

<iframe 
src="https://www.pacsbin.com/c/ZJ4og7kiGc?s=659dc2acf652e35c34e1565e&i=659dc2acf652e35c34e1565f&ww=1500&wc=-500&an=false&header=false&notes=false&overlay=false&scale=1.0" 
style="width: 670px; height: 670px; border: 0;"></iframe>

</div>
 
```
:::
:::

## Pulmonary accumulation of smoker's macrophages

![](images/smokersmacrophages.jpg){fig-align="center" width="80%"}

![](images/macrophagespraycan.jpg){fig-align="center" width="80%"}

It's a matter of how many I put there with my *macrophage spray can*...

## Terminology that is deserving of abandonment

<br> <br>

![](images/smokersmacrophagesannotated.jpg){fig-align="center" width="100%"}

<br>

Should we *really* discard DIP ?

## Yes!

<br>

![](images/dipNOT.jpg){fig-align="center" width="100%"}

## We need to pursue meaningful precision

<br>

![](images/dolphinsnotbigfish.jpg){fig-align="center" width="100%"}

## Smoking-related Interstitial Fibrosis

<br>

::: columns
::: {.column width="50%"}
Pathology

Distinctive accumulation of swaths of "ropey collagen," particularly in the subpleural lungs

![](images/ropeycollagen.jpg){fig-align="center" width="70%"} <br> arrow: ropey collagen arrowhead: pigmented smoker's macrophages
:::

::: {.column width="50%"}
<br>

![](images/srif.jpg){fig-align="center" width="100%"}

[Source: Vehar, et al.SRIF https://doi.org/10.1093/ajcp/aqac144]{style="color: gray; font-size: 18px;"}

<br>

Yes, we cannot tell how much of the opacity is SRIF versus Smoker's Macrophages versus both!
:::
:::

## Smoker's Lung

<br> <br>

![](images/smokerslung.jpg){fig-align="center" width="100%"} <br>

**Suggested reporting terminology**

"Findings of Smoker's Lung are present in the form of: centrilobular emphysema in the upper lungs and patchy pulmonary ground glass opacities, consistent with accumulation of Smoker's Macrophages and/or Smoking-Related Interstitial Fibrosis."

## Smoker's Lung -- example two

<br> <br>

![](images/smokerslungtwo.jpg){fig-align="center" width="100%"}

## Smoker's Lung -- example three

<br> <br>

![](images/smokerslungthree.jpg){fig-align="center" width="100%"}

## Combined emphyema and fibrosis syndrome

<br>

::: columns
::: {.column width="50%"}
<br> <br>

![](images/ATSstatement.jpg){fig-align="left" width="100%"} <br> <br>

![](images/cpfeproposeddefinition.jpg){fig-align="left" width="100%"}
:::

::: {.column width="50%"}
![](images/cpfe.jpg){fig-align="center" width="50%"}
:::
:::

## Smoking-related Acute Eosonophilic Pneumonia

<br>

![](images/aepfirstsmoker.jpg){fig-align="center" width="100%"}

::: {.callout-note icon="false"}
## Attributing a cause-and-effect relationship

-   has been the subject of Case Reports
-   typically occurs in young people who very recently (usually days) started smoking
-   no alternative cause of esosinophilia is apparent
-   consistent imaging findings
:::
